Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years
Alexander D. Heini(University of Bern), Thomas Pabst(University Hospital of Bern), Urban Novak(University of Bern), Katja Seipel(University of Bern), Kurt Leibundgut(Swiss Red Cross), Gabriela M. Baerlocher(Terry Fox Research Institute), Behrouz Mansouri Taleghani(University of Bern), Yara Banz(Beth Israel Deaconess Medical Center), Martin D. Berger(University of Bern)
Cited by 27
Related Papers
Mutations in <i>TERT,</i> the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
|New England Journal of Medicine|2005|717
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
|Leukemia|2012|417